KROS - Keros Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

KROS is currently covered by 2 analysts with an average price target of $19. This is a potential upside of $7.92 (71.48%) from yesterday's end of day stock price of $11.08.

Keros Therapeutics's activity chart (see below) currently has 97 price targets and 82 ratings on display. The stock rating distribution of KROS is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 35.17% of the time, taking 72.52 days on average.

Highest price target for KROS is $20, Lowest price target is $18, average price target is $19.

Most recent stock forecast was given by BENJAMIN BURNETT from WELLS FARGO on 04-Aug-2026. First documented stock forecast 04-May-2020.

Currently out of the existing stock ratings of KROS, 2 are a HOLD (50%), 2 are a BUY (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Mar-2026

$18

$6.92 (62.45%)

$20

3 months 17 days ago
(04-Aug-2026)

0/3 (0%)

$7.75 (75.61%)

Hold Since 28-Nov-2025

$19

$8.01 (72.88%)

$18

11 months 24 days ago
(28-Nov-2025)

2/2 (100%)

$1.52 (8.70%)

91

Buy Since 31-Jul-2023

$27

$23

1 years 9 days ago
(12-Nov-2025)

0/8 (0%)

$9.53 (54.55%)

Hold Since 01-Apr-2025

$16

$15

1 years 15 days ago
(06-Nov-2025)

4/4 (100%)

$-0.17 (-1.05%)

80

Buy Since 04-May-2020

$20

$25

1 years 3 months 11 days ago
(10-Aug-2025)

2/15 (13.33%)

$6.27 (45.67%)

115

Show more analysts

Please expand the browser size to see the chart

What is KROS (Keros Therapeutics) average time for price targets to be met?

On average it took 73 days for the stock forecasts to be reached, with an average price target met ratio of 35.17%.

Which analyst most recently updated their price target on KROS (Keros Therapeutics)?

Benjamin Burnett

Which analyst has the most public recommendations on KROS (Keros Therapeutics)?

Benjamin Burnett works at WELLS FARGO and has 19 price targets and 18 ratings on KROS

Which analyst is the currently most bullish on KROS (Keros Therapeutics)?

Tom Smith with the highest potential upside of $69.39

Which analyst is the currently most reserved on KROS (Keros Therapeutics)?

Julian Harrison with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?